Our impact
Behind every scientific advance that CEPI supports are teams of passionate scientists, healthcare workers, and frontline workers, who are dedicated to advancing the development of new vaccines to save lives and create a safer world for everyone. Read our impact stories to learn more.
50+
CEPI-supported vaccine candidates or platform technologies
Nearly 2 billion
COVID-19 doses delivered through COVAX, co-led by CEPI
30+
Governments and philanthropic foundations supporting CEPI
250+
R&D partners collaborating with CEPI
Clinical trials in remote rainforests: how vital Ebola research in DRC enhances local expertise and infrastructure
Prof. Hypolite Muhindo-Mavoko talks about the challenges and rewards that come with conducting vaccine trials for deadly viruses in the isolated city of Boende
“For the entire world”: a Uganda research facility steps up to catch the next pandemic bug
Joining the CEPI-run Centralized Laboratory Network starts a new chapter in the almost century-long history of the illustrious Uganda Virus Research Institute.
From the pain of Ebola to the passion to fight Lassa
"We push ourselves forward in our work because we feel the weight of the Lassa problem and we know the burden of the disease."
The Race to Future-Proof Coronavirus Vaccines
To help humanity get ahead, we need vaccines that provide broad protection against new variants of COVID-19 as well as future coronavirus threats.
Monitoring, Evaluation and Learning
Our 2022-2026 strategy, CEPI 2.0, is supported by three strategic objectives: PREPARE, TRANSFORM and CONNECT.
We monitor and evaluate progress against expected outcomes and outputs for each strategic objective and use these findings to improve our strategy and operations.
Each year, CEPI tracks progress of its accomplishments alongside the new projects and partnerships launched to ensure we remain on track to meet our goals.
All Annual Progress Reports and other independent reviews of our work, such as the independent evaluation of our first five-year strategy, are available on our website.
As we are half-way through CEPI 2.0, we have launched a Mid-Term Review to take stock of the overall progress made since the strategy launched. This includes looking at our goals and objectives, achieved or expected results and the performance of our governance & management bodies.
The Mid-Term Review allows us to identify areas where we need to reinforce or refine efforts for the remainder of the strategic period.
A consortium of independent external evaluators is leading the review, overseen by an independent evaluation committee.
Further details will be shared in the coming months.
